Brief: Ayrton Capital Llc Reports 6.65% Passive Stake In Sunesis Pharmaceuticals As Of July 29
Aug 7 (Reuters) -
* AYRTON CAPITAL LLC REPORTS 6.65% PASSIVE STAKE IN SUNESIS
PHARMACEUTICALS AS OF JULY 29-SEC FILING
Source text - https://bit.ly/3adep5O
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update